polycystic%20ovarian%20syndrome
POLYCYSTIC OVARIAN SYNDROME
Treatment Guideline Chart
Polycystic ovarian syndrome (PCOS) is the accumulation of underdeveloped follicles in the ovaries due to anovulation. It is is characterized by menstrual abnormalities and clinical or biochemical features of hyperandrogenism.
It results mainly from abnormal steroidogenesis that may be caused by insulin resistance leading to hyperinsulinemia.
There is increased sensitivity to androgens and the majority of women have elevated androgen levels.

Polycystic Ovarian Syndrome Drug Information

Drug Information

Indication: Monotherapy or adjunct to sulfonylurea for NIDDM when hyperglycemia cannot be controlled by diet management, e...

Indication: Type 2 DM in adult particularly in overwt patients when dietary management & exercise alone does not resul...

Indication: Type 2 DM. May be used as monotherapy or in combination w/ other oral antidiabetic agents or insulin. Adjuvant...

Indication: Anovulation including polycystic ovarian syndrome in women unresponsive to treatment w/ clomiphene citrate. St...

Indication: Type 2 DM in overwt adults when dietary management & exercise alone do not result in adequate glycemic con...

Indication: Men w/ pattern hair loss (androgenetic alopecia).

Indication: Primary or secondary adrenocortical insufficiency; endocrine, rheumatic, collagen, dermatologic, ophth, resp, ...

Indication: Monotherapy or in combination w/ sulfonylurea for maturity onset DM not responsive to diet.

Amaryl M SR
glimepiride + metformin hydrochloride
2  /  5
Editor's Recommendations